阿尔本达 - 伊弗梅克丁组合降低了实验性神经囊硬化症的炎症
Rafael Caetano da Silva Santana1, Tiago Paiva Prudente1, Carlos Henrique de Sousa Guerra2
1Medicine School, Federal University of Goias, Goiânia, Goiás, CEP: 74605-050, Brazil.
Experimental parasitology
|June 16, 2023
概括
神经囊硬化症 (NCC) 的治疗可以通过结合阿尔本达 (ABZ) 和伊弗梅克丁 (IVM) 来改善. 在实验模型中,这种组合表明减少了炎症和寄生虫退化,为这种严重的神经疾病提供了潜在的替代化疗.
科学领域:
- 神经寄生虫学 神经寄生虫学
- 实验神经学 实验神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经囊硬化 (NCC) 是一个重要的公共卫生问题,也是流行地区神经系统疾病的主要可预防的原因.
- 目前的NCC治疗包括像阿尔本达 (ABZ) 这样的抗药与抗炎药物相结合,以控制寄生虫死亡引起的炎症.
- 甲素 (IVM) 是一种甲药,具有已知的抗炎性质.
研究的目的:
- 为了研究阿尔本达-艾弗梅克丁 (ABZ-IVM) 联合治疗对实验性神经囊性瘤的组织病理效应.
- 评估ABZ-IVM作为NCC潜在替代化疗疗法的疗效.
主要方法:
- 在Balb/c小鼠中,通过用*T. crassiceps* cysticerci.的内注射诱导实验性神经囊病.
- 小鼠接受了盐水 (对照剂),阿尔本达单独治疗,艾弗梅克丁单独治疗或阿尔本达和艾弗梅克丁的组合治疗.
- 在治疗后24小时内,对大脑进行了基因病理学分析,以评估寄生虫退化和炎症反应.
主要成果:
- 与对照剂和阿尔本达单独治疗相比,单独治疗ivermectin和ABZ-IVM组合都表现出较高程度的囊退化.
- 在ABZ-IVM组合和IVM单疗群体中,炎症透,脑膜炎和高血压的减少.
- 组织病理学分析表明,含IVM的治疗方法显著降低了炎症标志物.
结论:
- 阿尔本达 (albendazole) 和艾弗梅克丁 (ivermectin) 的组合在实验性NCC中显示出有希望的抗寄生虫和抗炎作用.
- 这种联合治疗有可能减轻与中枢神经系统中的寄生虫死亡相关的不良炎症反应.
- 可以推ABZ-IVM作为神经囊硬化症的替代化疗,通过解决寄生虫负荷和炎症来改善治疗结果.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
202
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
202
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
161
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
161
01:29Drugs for Treatment of Ulcerative Colitis in IBD
179
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
179